.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India's biotech sector growth has reached a major milestone. Specifically, the industry expanded from $10 billion to over $195 billion within a single decade. Union Minister Dr. Jitendra Singh announced this leap at BIRAC’s 14th Foundation Day. This rapid expansion reflects a robust 18% annual growth rate. Consequently, the sector now contributes approximately 4.8% to the national GDP.
Several factors have catalyzed this massive expansion since 2014. Firstly, the government established an enabling policy environment that prioritizes science and technology. Additionally, BIRAC has emerged as a critical interface between public and private sectors. It facilitates targeted funding, mentorship, and industry-academia partnerships. Consequently, the number of biotech startups in India has skyrocketed from just 50 to over 11,800 today.
Moreover, the launch of the BioE3 Policy marks a significant strategic shift. This policy focuses on economy, environment, and employment by promoting sustainable biomanufacturing. For instance, the government is setting up biofoundries and Bio-AI hubs to support deep-tech innovation. Therefore, these initiatives ensure that India remains a global leader in precision medicine and biopharmaceuticals.
India is now on a clear path to becoming the world’s third-largest economy. The country aims to reach a $300 billion bioeconomy by 2030. To achieve this, the government is utilizing a ₹1 lakh crore Research, Development, and Innovation (RDI) Fund. This fund supports high-risk scientific innovation and clinical research. Although challenges like the COVID-19 pandemic existed, the sector demonstrated remarkable resilience. Specifically, the biopharma segment remains the largest contributor, accounting for 35% of the total bioeconomy value.
Q1: What is the current value of India's bioeconomy?
As of March 2026, India's bioeconomy is valued at approximately $195.3 billion, having grown from $10 billion in 2014.
Q2: What is the role of BIRAC in this growth?
BIRAC acts as a model institution that bridges the gap between academia and industry. It provides risk capital, infrastructure support, and mentorship to over 11,000 startups.
Q3: What is the target for India's biotech sector by 2030?
The Indian government has set an ambitious target to reach a $300 billion bioeconomy by the year 2030.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
India’s biotech sector surged to $195 billion, driven by BIRAC, over 11,800 startups, and strategic policies like BioE3, aiming for $300 billion by 2030....
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
